Connect with us

Research Reports

The Electrophysiology Ablation Market Check Through Steadiness Between 2018-2026

The Personal Watercraft Market To Fathom The Depth Of Innovation

 

Considered as the first line of treatment for arrhythmias, demand for electrophysiology ablation procedures is projected to increase 2X

Lying in the high growth-low revenue quadrant, the global electrophysiology ablation market is anticipated to expand at a stellar annual growth rate of 9.1 percent, standing at a valuation of US$ 2.3 Billion by 2019 end, as per a recent market analysis by Persistence Market Research. The growing demand for electrophysiology (EP) is attributed to the advancing EP technologies with new ablation tools to improve atrial fibrillation (AF) treatments. Moreover, implantable rhythm management devices for less invasive procedures combines with miniaturized diagnostic monitoring systems are also pumping revenue into the global electrophysiology ablation market. In addition, electrophysiology ablation being the first line of treatment for arrhythmias, considered superior to antiarrhythmic drugs, is anticipated to be a key factor contributing to the electrophysiology ablation procedures.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25474

Company Profiles:

  • Abbott
  • Boston Scientific
  • Biosense Webster (Johnson&Johnson)
  • MEDTRONIC PLC
  • CathRx Ltd
  • Biotronik SE & Co. KG.
  • Japan Lifeline Co
  • ATRICURE, INC.
  • Auris Health
  • Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25474

Rehospitalization after Ablation Catheter Could Pose Challenges

Considered as the most superior treatment form for patients with drug refractory scar-associated ventricular tachycardia (VT), ablation catheter is also known to result in patients developing comorbidities such as congestive heart failure (CHF) and pulmonary disease, specifically in patients with myocardial infarction-associated VT. Increased risks and complications associated with ablation catheter, translate into frequent hospital admissions and higher cumulative hospital costs.

  • As per PMR analysis, in terms of product type, ablation catheter segment is projected to account for nearly 48.0% revenue share of the global electrophysiology ablation market, majorly attributable to the increasing demand for them in hospitals and community set ups combined with efficient product developments, wherein newer treatments for AF use ablation catheter focusing on specific areas of the heart to yield better outcomes.

However, several innovations and research have emerged around new mapping systems, allowing cardiologists, to view the source of atrial fibrillation. For instance, the Fixed Chaotic Sinning Approach, Atrial Fibrillation Driver Ablation, and 3-D Imaging for Ablation are some promising innovations, anticipated to determine the future of ablation catheter for AF. In the future, one could also expect robotic-driven advanced mapping and magnetic systems in the form of Stereotaxis for curing arrhythmia, amongst other novel innovations”, explained the analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25474

Opportunity Analysis: Multiple Use of Conventional Catheters

Although, the electrophysiology ablation market is dominated by the top four leading players, emerging companies are projected to develop revolutionary products, thereby broadening the application scope. For instance, CathRx’s ground-breaking range of electrophysiology catheters called Khelix, is stated to be the first ‘reposable’ diagnostic and therapeutic catheters for the treatment of cardiac arrhythmias—allowing it to be used for 20 times in general practice of electrophysiology.

Leading companies in the electrophysiology ablation landscape are prominently focusing on developing efficient catheters to meet stringent regulatory standards set by governments of various countries, thereby reducing product recalls. Moreover, studies suggest significant price differences between countries and significant variations in competitors’ market shares across the EEA countries. The electrophysiology ablation market analysis by PMR offers deeper insights on how innovative technologies to cure arrhythmia, could shape the growth trajectory of electrophysiology ablation procedures. 

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Continue Reading
Editorial & Advertiser disclosure

Recommended